MIRM — Mirum Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Mirum Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	117	232	157	152	286
Net Total Accounts Receivable
Net Total Receivables	—	—	3.27	24	68
Total Inventory
Prepaid Expenses
Total Current Assets	119	236	167	190	388
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.73	3.24	2.55	2.35	1.99
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	147	241	295	353	647
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	13.1	18.5	42.6	64.7	87.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	16.4	68.8	174	211	398
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	130	172	120	142	249
Total Liabilities & Shareholders' Equity	147	241	295	353	647
Total Common Shares Outstanding